
Profound Medical Corp
TSX:PRN

Operating Margin
Profound Medical Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
CA |
![]() |
Profound Medical Corp
TSX:PRN
|
189.9m CAD |
-310%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
215.6B USD |
17%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.4B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
136.5B USD |
18%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
132.9B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
105.9B USD |
19%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
57.7B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
48.2B EUR |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
40.2B USD |
27%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.4B CNY |
36%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
31.2B USD |
29%
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Profound Medical Corp's most recent financial statements, the company has Operating Margin of -309.6%.